Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up

Overview

Journal Horm Res Paediatr

Publisher Karger

Specialties Endocrinology
Pediatrics

Date 2019 Feb 1

PMID 30703774

Citations 7

Authors

Hanneke M van Santen

Marry M van den Heuvel-Eibrink

Marianne D van de Wetering

W Hamish Wallace

Affiliations

Soon will be listed here.

Abstract

Hypogonadism after treatment for childhood cancer is a recognized complication and its cause may be subdivided into primary gonadal failure and central hypogonadism. Here, we provide an overview of the risk factors for the development of hypogonadism, assessment and potential interventions and give a summary of the current recommendations for management and follow-up of hypogonadism in childhood cancer survivors.

Citing Articles

Causality between Sex Hormones and Bone Mineral Density in Childhood: Age- and Tanner-Stage-Matched Sex Hormone Level May Be an Early Indicator of Pediatric Bone Fragility.

Kim S, Kim S, Kim S, Cho W, Cho K, Jung M Biomedicines. 2024; 12(6).

PMID: 38927380 PMC: 11200954. DOI: 10.3390/biomedicines12061173.

Late Complications in Long-Term Childhood Cancer Survivors: What the Oral Health Professional Needs to Know.

Al-Ansari S, Stolze J, Bresters D, Brook A, Laheij A, Brand H Dent J (Basel). 2024; 12(1).

PMID: 38275678 PMC: 10813876. DOI: 10.3390/dj12010017.

Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer.

Jin H, Lee J, Park M, Park H Cancer Res Treat. 2023; 55(3):992-1000.

PMID: 36731461 PMC: 10372588. DOI: 10.4143/crt.2022.1518.

Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives.

Rossi F, Tortora C, Paoletta M, Marrapodi M, Argenziano M, Di Paola A Cancers (Basel). 2022; 14(18).

PMID: 36139510 PMC: 9496695. DOI: 10.3390/cancers14184349.

Long-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors.

Hudson M, Bhatia S, Casillas J, Landier W Pediatrics. 2021; 148(3).

PMID: 34462344 PMC: 9014377. DOI: 10.1542/peds.2021-053127.

References

Levine J, Kelvin J, Quinn G, Gracia C . Infertility in reproductive-age female cancer survivors. Cancer. 2015; 121(10):1532-9. DOI: 10.1002/cncr.29181. View

Dewailly D, Andersen C, Balen A, Broekmans F, Dilaver N, Fanchin R . The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014; 20(3):370-85. DOI: 10.1093/humupd/dmt062. View

Kelsey T, McConville L, Edgar A, Ungurianu A, Mitchell R, Anderson R . Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors. PLoS One. 2017; 12(7):e0181377. PMC: 5519149. DOI: 10.1371/journal.pone.0181377. View

Wallace W, Thomson A, Saran F, Kelsey T . Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005; 62(3):738-44. DOI: 10.1016/j.ijrobp.2004.11.038. View

Palmert M, Dunkel L . Clinical practice. Delayed puberty. N Engl J Med. 2012; 366(5):443-53. DOI: 10.1056/NEJMcp1109290. View

Rendtorff R, Beyer M, Muller A, Dittrich R, Hohmann C, Keil T . Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors. Andrologia. 2011; 44 Suppl 1:219-25. DOI: 10.1111/j.1439-0272.2011.01167.x. View

de Michele F, Vermeulen M, Wyns C . Fertility restoration with spermatogonial stem cells. Curr Opin Endocrinol Diabetes Obes. 2017; 24(6):424-431. DOI: 10.1097/MED.0000000000000370. View

Anderson R, Mitchell R, Kelsey T, Spears N, Telfer E, Wallace W . Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol. 2015; 3(7):556-67. DOI: 10.1016/S2213-8587(15)00039-X. View

van Dorp W, van den Heuvel-Eibrink M, de Vries A, Pluijm S, Visser J, Pieters R . Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer. Hum Reprod. 2013; 29(2):337-42. DOI: 10.1093/humrep/det442. View

10.

Rossetti R, Ferrari I, Bonomi M, Persani L . Genetics of primary ovarian insufficiency. Clin Genet. 2016; 91(2):183-198. DOI: 10.1111/cge.12921. View

11.

Chow E, Antal Z, Constine L, Gardner R, Wallace W, Weil B . New Agents, Emerging Late Effects, and the Development of Precision Survivorship. J Clin Oncol. 2018; 36(21):2231-2240. PMC: 6053298. DOI: 10.1200/JCO.2017.76.4647. View

12.

Green D, Kawashima T, Stovall M, Leisenring W, Sklar C, Mertens A . Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009; 27(16):2677-85. PMC: 2690392. DOI: 10.1200/JCO.2008.20.1541. View

13.

Uijldert M, Meissner A, de Melker A, van Pelt A, van de Wetering M, van Rijn R . Development of the testis in pre-pubertal boys with cancer after biopsy for fertility preservation. Hum Reprod. 2017; 32(12):2366-2372. DOI: 10.1093/humrep/dex306. View

14.

Picton H, Wyns C, Anderson R, Goossens E, Jahnukainen K, Kliesch S . A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys. Hum Reprod. 2015; 30(11):2463-75. DOI: 10.1093/humrep/dev190. View

15.

van Dorp W, Haupt R, Anderson R, Mulder R, van den Heuvel-Eibrink M, van Dulmen-den Broeder E . Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review. J Clin Oncol. 2018; 36(21):2169-2180. PMC: 7098836. DOI: 10.1200/JCO.2017.76.3441. View

16.

Rohayem J, Hauffa B, Zacharin M, Kliesch S, Zitzmann M . Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clin Endocrinol (Oxf). 2016; 86(1):75-87. DOI: 10.1111/cen.13164. View

17.

Crofton P, Thomson A, Evans A, Groome N, Bath L, Kelnar C . Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?. Clin Endocrinol (Oxf). 2003; 58(3):296-301. DOI: 10.1046/j.1365-2265.2003.01712.x. View

18.

Green D, Kawashima T, Stovall M, Leisenring W, Sklar C, Mertens A . Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 28(2):332-9. PMC: 2815721. DOI: 10.1200/JCO.2009.24.9037. View

19.

Green D, Nolan V, Goodman P, Whitton J, Srivastava D, Leisenring W . The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2013; 61(1):53-67. PMC: 3933293. DOI: 10.1002/pbc.24679. View

20.

Burgos N, Cintron D, Latortue-Albino P, Serrano V, Gutierrez R, Faubion S . Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review. Endocrine. 2017; 58(3):413-425. PMC: 5765545. DOI: 10.1007/s12020-017-1435-x. View